Apolipoprotein E ε4 allele frequency and age at onset of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 1, 2006, Pages 60-66

  Davidson, Yvonne ^a   Gibbons, Linda ^a   Pritchard, Antonia ^b   Hardicre, Jayne ^a   Wren, Joanne ^a   Stopford, Cheryl ^a   Julien, Camille ^a   Thompson, Jennifer ^a   Payton, Antony ^a   Pickering Brown, Stuart M ^a   Pendleton, Neil ^a   Horan, Michael A ^a   Burns, Alistair ^a   Purandare, Nitin ^a   Lendon, Corinne L ^b   Neary, David ^a   Snowden, Julie S ^a   Mann, David M A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

4 allele; Alzheimer's disease; Apolipoprotein E gene

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; COGNITIVE DEFECT; GENETICS; HOSPITALIZATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 33845800866     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097038     Document Type: Article

References (24)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel D, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994;7:180-184.
3. Farrer LA, Cupples A, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, Van Duijn; and Alzheimer Disease Meta Analysis Consortium: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997;278:1349-1356.
4. Van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, van Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78.
5. Houlden H, Crook R, Backhovens H, Prihar G, Baker M, Hutton M, Rossor M, Martin JJ, Van Broeckhoven C, Hardy J: ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Am J Med Genet 1998;81:117-121.
6. Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Perez-Tur J, Michon A, Dubois B, Ledoze F, Thomas-Anterion C, Pasquier F, Puel M, Demonet JF, Moreaud O, Babron MC, Meulien D, Guez D, Chartier-Harlin MC, Frebourg T, Agid Y, Martinez M, Clerget-Darpoux F: Apolipoprotein E and Alzheimer disease: genotype specific risks by age and sex. Am J Hum Genet 1997;60:439-436.
7. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the Auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
9. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease. II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
10. Pendleton N, Payton A, van den Boogerd EH, Holland F, Diggle P, Rabbitt PMA, Horan MA, Worthington J, Ollier WER: Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neurosci Lett 2002;324:74-76.
11. Rabbitt P, Diggle P, Smith D, Holland F, Mc-Innes L: Identifying and separating the effects of practice and of cognitive ageing during a large longitudinal study of elderly community residents. Neuropsychologia 2001;39:532-543.
12. Wenham PR, Price WH, Blundell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
13. Wrelkin N: Consensus statement on apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347:1091-1099.
14. Kennedy AM, Newman SK, Frackowiak RSJ, Cunningham VJ, Roques P, Stevens J, Neary D, Bruton CJ, Warrington EK, Rossor MN: Chromosome 14 linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree. Brain 1995;118:185-205.
15. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, Hardy J, Hutton M, Stevens JM, Warrington EK, Rossor MN: Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Brain 1997;120:490-501.
16. Houlden H, Collinge J, Kennedy A, Newton S, Rossor M, Lannfelt L, Lilius L, Winblad B, Crook R, Duff K, Hardy J: ApoE genotype is a determinate of onset age in families with Alzheimer's disease and APP mutations. Lancet 1993;342:737-738.
17. Van Broeckhoven C, Backhovens H, Cruts M, Martin JJ, Crook R, Houlden H, Hardy J: ApoE genotype does not modulate age at onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994;169:179-180.
18. 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral haemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996;148:1257-1266.
19. 42(43). Ann Neurol 1996;40:149-156.
20. Mann DMA, Pickering-Brown S, Baba M, Iwatsubo T: Amyloid angiopathy and variability in Aβ deposition in PS-1 linked Alzheimer's disease. Am J Pathol 2001;158:2165-2175.
21. Pastor P, Roe CM, Villegas A, Bedoya G, Chakraverty S, Garcia G, Tirado V, Norton J, Rios S, Martinez M, Kosik KS, Lopera F, Goate AM: Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol 2003;54:163-169.
22. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M: Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-1315.
23. Hofman A, Ott A, Breteler M, Slooter AJC, van Harskamp F, van Duijn CN, van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-154.
24. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R: Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based study. JAMA 1997;277:818-821.